Antibiotics — Revision Notes

⚡ 30-Second Revision

Antibiotics: — Chemicals that kill or inhibit bacterial growth.
Discovery: — Alexander Fleming (1928) - Penicillin from *Penicillium notatum*. Florey & Chain (1940s) - purified for therapeutic use.
Selective Toxicity: — Harm bacteria, spare host cells.
Spectrum:

- Narrow-spectrum: Few bacteria (e.g., Penicillin G). - Broad-spectrum: Wide range (e.g., Tetracyclines).

Effect:

- Bactericidal: Kills bacteria (e.g., Penicillins, Aminoglycosides). - Bacteriostatic: Inhibits growth (e.g., Tetracyclines, Macrolides).

Mechanisms of Action (MoA):

- Cell Wall Synthesis Inhibitors: Beta-lactams (Penicillins, Cephalosporins), Vancomycin. - Protein Synthesis Inhibitors: - 30S Ribosome: Aminoglycosides (bactericidal), Tetracyclines (bacteriostatic). - 50S Ribosome: Macrolides (bacteriostatic), Chloramphenicol (bacteriostatic). - Nucleic Acid Synthesis Inhibitors: Fluoroquinolones (DNA gyrase), Rifampicin (RNA polymerase). - Metabolic Pathway Inhibitors: Sulfonamides, Trimethoprim (folic acid synthesis).

Antibiotic Resistance: — Bacteria evolve to withstand antibiotics.

- Mechanisms: Enzymatic inactivation (e.g., $\beta$-lactamase), altered target site, efflux pumps, reduced uptake. - Causes: Misuse, overuse, incomplete courses.

2-Minute Revision

Antibiotics are microbial-derived or synthetic compounds that selectively target and inhibit the growth of or kill bacteria. Their discovery by Alexander Fleming (penicillin) marked a revolution in medicine.

The core principle is 'selective toxicity,' meaning they harm bacteria without significantly damaging host cells, achieved by targeting unique bacterial structures like the peptidoglycan cell wall or 70S ribosomes.

Antibiotics are classified as narrow-spectrum (targeting few bacteria) or broad-spectrum (targeting many), and as bactericidal (killing bacteria) or bacteriostatic (inhibiting growth). Key mechanisms of action include inhibiting cell wall synthesis (e.

g., Penicillins), protein synthesis (e.g., Tetracyclines on 30S, Macrolides on 50S), nucleic acid synthesis (e.g., Fluoroquinolones), or metabolic pathways (e.g., Sulfonamides). A critical challenge is antibiotic resistance, where bacteria develop mechanisms like enzymatic inactivation, target modification, or efflux pumps.

Misuse and incomplete courses accelerate resistance, making responsible use vital.

5-Minute Revision

Antibiotics are powerful chemical agents, predominantly of microbial origin, designed to combat bacterial infections by selectively inhibiting bacterial growth or killing them. The accidental discovery of penicillin by Alexander Fleming in 1928, and its subsequent purification and therapeutic application by Florey and Chain, ushered in the antibiotic era.

The fundamental concept underpinning antibiotic efficacy is 'selective toxicity,' where the drug targets specific bacterial components (like the peptidoglycan cell wall, unique 70S ribosomes, or specific enzymes for DNA/RNA synthesis or metabolic pathways) that are absent or significantly different in human cells, thereby minimizing host damage.

Antibiotics are categorized by their spectrum of activity: 'narrow-spectrum' (effective against a limited range, e.g., Penicillin G for Gram-positives) and 'broad-spectrum' (effective against a wide range, e.g., Tetracyclines for both Gram-positive and Gram-negative). They are also classified by their effect: 'bactericidal' (kill bacteria, e.g., Penicillins, Aminoglycosides) or 'bacteriostatic' (inhibit growth, e.g., Tetracyclines, Macrolides).

Understanding their mechanisms of action is crucial:

1
Cell wall synthesis inhibitors — (e.g., Beta-lactams like Penicillins, Cephalosporins, and Glycopeptides like Vancomycin) interfere with peptidoglycan formation, leading to cell lysis.
2
Protein synthesis inhibitors — target bacterial 70S ribosomes. Aminoglycosides and Tetracyclines bind to the 30S subunit, while Macrolides and Chloramphenicol bind to the 50S subunit.
3
Nucleic acid synthesis inhibitors — (e.g., Fluoroquinolones, Rifampicin) interfere with DNA replication or RNA transcription.
4
Metabolic pathway inhibitors — (e.g., Sulfonamides, Trimethoprim) block essential bacterial metabolic processes like folic acid synthesis.

The most pressing issue in antibiotic therapy is antibiotic resistance, where bacteria evolve mechanisms to survive antibiotic exposure. These mechanisms include producing enzymes (e.g., beta-lactamases) to inactivate the drug, altering the antibiotic's target site (e.

g., modified PBPs in MRSA), actively pumping the drug out of the cell (efflux pumps), or reducing drug uptake. Misuse, overuse, and incomplete courses of antibiotics accelerate the development and spread of resistance, making infections harder to treat.

Responsible antibiotic stewardship is paramount to preserve their effectiveness.

Prelims Revision Notes

Antibiotics are chemical substances, primarily produced by microorganisms (fungi, bacteria) or synthesized, that selectively inhibit the growth of or kill other microorganisms, mainly bacteria. Their discovery by Alexander Fleming (Penicillin from *Penicillium notatum*) in 1928, and subsequent development by Florey and Chain, revolutionized medicine.

The core principle is selective toxicity, meaning they target bacterial structures (e.g., peptidoglycan cell wall, 70S ribosomes) or metabolic pathways unique to bacteria, minimizing harm to host cells.

Classification:

Spectrum of Activity:

* Narrow-spectrum: Effective against a limited range of bacteria (e.g., Penicillin G, primarily Gram-positive). * Broad-spectrum: Effective against a wide range of bacteria (both Gram-positive and Gram-negative, e.g., Tetracyclines, Chloramphenicol). Can disrupt normal microbiota.

Effect on Bacteria:

* Bactericidal: Kill bacteria directly (e.g., Penicillins, Cephalosporins, Aminoglycosides, Fluoroquinolones). * Bacteriostatic: Inhibit bacterial growth, allowing host immunity to clear (e.g., Tetracyclines, Macrolides, Chloramphenicol, Sulfonamides).

Mechanisms of Action (MoA) - High Yield for NEET:

1
Inhibition of Cell Wall Synthesis: — Target peptidoglycan cross-linking. Examples: Beta-lactams (Penicillins, Cephalosporins) bind to PBPs; Glycopeptides (Vancomycin) bind to D-Ala-D-Ala.
2
Inhibition of Protein Synthesis: — Target bacterial 70S ribosomes.

* 30S Subunit: Aminoglycosides (bactericidal, misreading mRNA); Tetracyclines (bacteriostatic, block tRNA binding). * 50S Subunit: Macrolides (bacteriostatic, inhibit translocation); Chloramphenicol (bacteriostatic, inhibit peptidyl transferase).

1
Inhibition of Nucleic Acid Synthesis:

* Fluoroquinolones: Inhibit DNA gyrase/topoisomerase IV (DNA replication). * Rifampicin: Inhibits bacterial RNA polymerase (transcription).

1
Inhibition of Metabolic Pathways: — Antimetabolites.

* Sulfonamides: Inhibit folic acid synthesis by competing with PABA. * Trimethoprim: Inhibits dihydrofolate reductase (often used with sulfonamides).

Antibiotic Resistance: A major global health crisis. Bacteria develop resistance through:

Enzymatic Inactivation: — Producing enzymes (e.g., $\beta$-lactamases) that degrade the antibiotic.
Alteration of Target Site: — Modifying the bacterial target molecule (e.g., mutated PBPs in MRSA, altered ribosomal binding sites).
Reduced Uptake: — Decreasing membrane permeability to the antibiotic.
Efflux Pumps: — Actively pumping the antibiotic out of the cell.

Causes: Overuse, misuse, incomplete courses, use in animal agriculture. Always complete the full prescribed course.

Vyyuha Quick Recall

To remember the main mechanisms of antibiotic action, think of 'Cell Protein Nucleic Acid Metabolism'.

Cell Protein Nucleic Acid Metabolism

Cell Wall: Penicillins, Cephalosporins, Vancomycin
Protein Synthesis: Aminoglycosides, Tetracyclines (30S); Macrolides, Chloramphenicol (50S)
Nucleic Acid Synthesis: Fluoroquinolones, Rifampicin
Metabolism (Folic Acid): Sulfonamides, Trimethoprim